Rahmenverträge für innovative Therapeutika gegen Infektionskrankheiten
Originaltitel der Bekanntmachung
Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Opportunity Score
Warum diese Bewertung?
Chance
72 / 100
Komplexität
88 / 100
Risikofaktoren
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- Health and Digital Executive Agency (HaDEA)
- Land
- Belgien
- CPV
- 73000000 - Research and development services and related consultancy services +1 weitere
- Frist
- Sep 02, 2026
- Geschätzter Wert
- EUR 252M
Überblick
Moderate opportunityWichtige Fakten
- EUR 252M estimated value
- Framework procurement
- Services contract
- 2 lots
- Development of innovative next-generation therapeutics for infectious diseases under competitive development phases within a Pre-Commercial Procurement model.
- Potential treatment areas include viral infections, infection-related acute respiratory distress syndrome, and sepsis.
Vollständige Zusammenfassung anzeigen
HaDEA is procuring two EU-funded framework service lots under a competitive phased Pre-Commercial Procurement procedure for innovative next-generation therapeutics for infectious diseases. The scope includes pathogen-targeted and host-targeted therapeutics, combination therapies, alternative administration routes, and therapies addressing viral infections, infection-related ARDS or sepsis. The total estimated value is EUR 252,000,000. Electronic submission through the Funding and Tenders Portal is required by 2 September 2026 at 14:00:59 UTC. The opportunity is substantial but requires detailed review of procurement documents that were not provided or analyzed.
Risiken
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- The procurement uses a competitive development in phases under Pre-Commercial Procurement and is structured as framework contracts.
Administrative
- Two lots are available and the notice states that a tenderer may submit for and be awarded a maximum of two lots.
- Electronic submission is required through the Funding and Tenders Portal submission endpoint.
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Lot 2
Auftraggeber
Ort
Brussels, BEL
Website
Kennung
HADEA
Tätigkeit
General public services
Lose (2)
LOT-0001
Highly Innovative Therapeutics
Framework service lot for pathogen-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Geschätzter Wert
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Please consult the procurement documents.
Zusätzliche CPV-Codes
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
Lot 1 targets pathogen targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
LOT-0002
Advanced Therapeutics
Framework service lot for host-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Geschätzter Wert
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Please consult the procurement documents.
Zusätzliche CPV-Codes
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
Lot 2 targets host targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
Vergabedetails
- Veröffentlichungsdatum
- 01 Jul 2026
- Sprachen
- English, Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32024R2509
Referenz-IDs
- Ausschreibungs-ID
- 456593-2026
Dokumente (2)
Ähnliche Ausschreibungen
Poland – Design and execution of research and development – Kompleksowa usługa CRO (Contract Research Organization) w niekomercyjnym badaniu klinicznym w ramach Projektu pod nazwą „Nowatorskie terapie genowe w leczeniu choroby Parkinsona oraz innych zaburzeń neurodegeneracyjnych”
Germany – Research and experimental development services – PR1260373 - Entwicklung einer Web-Plattform für den Betrieb produktnaher Audioanwendungen
Spain – Accounting, auditing and fiscal services – SDA servicios profesionales especializados
Norway – Research and development services and related consultancy services – Dynamic procurement scheme for biology and popular science assistance.
Norway – Architectural, construction, engineering and inspection services – Dynamic Purchasing System (DIO) procurement of consultancy services
Sweden-Uppsala: Research services
Opportunity Score
Warum diese Bewertung?
Chance
72 / 100
Komplexität
88 / 100
Risikofaktoren
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications